EMOR Stock Overview
Healixa Inc. operates as a technology company with assets in both healthtech and fintech.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Healixa Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.10 |
| 52 Week High | US$0.47 |
| 52 Week Low | US$0.071 |
| Beta | 0 |
| 1 Month Change | -28.74% |
| 3 Month Change | -42.82% |
| 1 Year Change | -75.00% |
| 3 Year Change | -90.91% |
| 5 Year Change | -93.33% |
| Change since IPO | -85.92% |
Recent News & Updates
Recent updates
Shareholder Returns
| EMOR | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | -11.1% | -0.09% | 3.3% |
| 1Y | -75.0% | -7.8% | 25.0% |
Return vs Industry: EMOR underperformed the US Healthcare Services industry which returned -7.8% over the past year.
Return vs Market: EMOR underperformed the US Market which returned 25% over the past year.
Price Volatility
| EMOR volatility | |
|---|---|
| EMOR Average Weekly Movement | 28.6% |
| Healthcare Services Industry Average Movement | 9.8% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: EMOR's share price has been volatile over the past 3 months.
Volatility Over Time: EMOR's weekly volatility has increased from 20% to 29% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1977 | n/a | Ian Parker | healixa.com |
Healixa Inc. operates as a technology company with assets in both healthtech and fintech. It offers tech solutions to enterprise partner channels across a range of industries, including employer benefits, travel, pharma, logistics, and other. Healixa Inc. also operates digital pharmacy marketplace.
Healixa Inc. Fundamentals Summary
| EMOR fundamental statistics | |
|---|---|
| Market cap | US$71.20m |
| Earnings (TTM) | US$0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs EMOR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EMOR income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$0 |
| Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did EMOR perform over the long term?
See historical performance and comparison